January 13, 2022 -- Quest Diagnostics reported preliminary results that suggest a decline in revenues for the fourth quarter of fiscal year 2021 (end-December 31). The company said that testing volumes outside of COVID-19 remain higher than they were before the pandemic.
For the period, Quest reported revenues of $2.74 billion, a decrease of 9% compared to $3 billion in 2020. The company added that total testing volume as measured by number of requisitions grew about 1.3% in the fourth quarter of 2021 versus the prior year.
The company noted that COVID-19 molecular testing volumes increased throughout the summer while its base business continued to deliver volume growth versus 2020 and 2019, showing a rebound in September.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current